Nodal connects hopeful parents with surrogates as reproductive freedom hangs in limbo [TechCrunch]
Progyny, Inc. (PGNY)
Last progyny, inc. earnings: 3/5 04:06 pm
Check Earnings Report
Company Research
Source: TechCrunch
Gestational surrogacy can be a great option for those individuals — if they can endure the lengthy wait times and afford to pay for the costly service. New York-based Nodal looks to make the process less expensive, more transparent, and faster. Nodal is a marketplace for prospective parents to get matched with vetted surrogates. Nodal founder and CEO Dr. Brian Levine told TechCrunch that his company wants to fix the industry's supply-and-demand problems. Dr. Brian Levine is the founder and CEO of Nodal. Courtesy of Nodal. Nodal takes the same technology-driven approach as life insurance companies to vet potential surrogates, Levine said, which speeds up the process and allows for more surrogates to be available. The marketplace approach also provides transparency for parents to have more control over which surrogate they work with. Nodal also cuts out middleman costs and works with fertility benefit companies like Carrot, Maven, and Progyny to lower the costs for prospective par
Show less
Read more
Impact Snapshot
Event Time:
PGNY
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
PGNY alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
PGNY alerts
High impacting Progyny, Inc. news events
Weekly update
A roundup of the hottest topics
PGNY
News
- World Class Health Secures $8M in Seed Funding to Expand Concierge Health Benefit with the largest Global Centers of Excellence network [Yahoo! Finance]Yahoo! Finance
- Johnson Fistel has Commenced an Investigation on Behalf of Progyny (PGNY) ShareholdersGlobeNewswire
- Progyny, Inc. (NASDAQ: PGNY) had its price target lowered by analysts at Barclays PLC from $30.00 to $17.00. They now have an "overweight" rating on the stock.MarketBeat
- Progyny, Inc. to Present at Jefferies London Healthcare ConferenceGlobeNewswire
- Progyny Third Quarter 2024 Earnings: Misses Expectations [Yahoo! Finance]Yahoo! Finance
PGNY
Earnings
- 11/12/24 - Beat
PGNY
Sec Filings
- 11/14/24 - Form SC
- 11/12/24 - Form 10-Q
- 11/12/24 - Form 8-K
- PGNY's page on the SEC website